Page last updated: 2024-10-29

isoproterenol and Tachycardia, Ventricular

isoproterenol has been researched along with Tachycardia, Ventricular in 109 studies

Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.

Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

Research Excerpts

ExcerptRelevanceReference
"To compare the arrhythmic response to isoproterenol and exercise testing in newly diagnosed arrhythmogenic right ventricular cardiomyopathy (ARVC) patients."7.88Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients. ( Cheniti, G; Cochet, H; Denis, A; Derval, N; Douard, H; Duchateau, J; Frontera, A; Haïssaguerre, M; Hocini, M; Jaïs, P; Kitamura, T; Lim, HS; Martin, C; Martin, R; Massoullie, G; Pambrun, T; Pillois, X; Sacher, F; Takigawa, M; Vlachos, K, 2018)
"To test this hypothesis, we studied the effect of isoproterenol on accessory pathway function and tachycardia induction in 18 patients (12 men and 6 women, ages 34 +/- 16 years [mean +/- SD]) with UACAP."5.08Effect of isoproterenol on accessory pathways without overt retrograde conduction. ( Klein, GJ; Li, HG; Yee, R, 1995)
"To compare the arrhythmic response to isoproterenol and exercise testing in newly diagnosed arrhythmogenic right ventricular cardiomyopathy (ARVC) patients."3.88Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients. ( Cheniti, G; Cochet, H; Denis, A; Derval, N; Douard, H; Duchateau, J; Frontera, A; Haïssaguerre, M; Hocini, M; Jaïs, P; Kitamura, T; Lim, HS; Martin, C; Martin, R; Massoullie, G; Pambrun, T; Pillois, X; Sacher, F; Takigawa, M; Vlachos, K, 2018)
" All 12 symptomatic patients and 1 asymptomatic sibling (mean age, 13+/-7 years) were found to have a relative resting bradycardia (64+/-13 bpm, versus 93+/-12 bpm in the unaffected siblings), as well as PVT induced by treadmill or isoproterenol infusion and appearing at a mean sinus rate of 110+/-10 bpm."3.71Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. ( Bahan, T; Eldar, M; Friedman, E; Goldman, B; Kastner, DL; Khoury, A; Lahat, H; Levy-Nissenbaum, E; Lorber, A; Pras, E, 2001)
"The frequency-dependent electrophysiologic effects of sematilide (n = 11) and amiodarone (n = 22) were determined at (1) drug-free baseline, (2) during steady-state (> 48 hours) dosing with sematilide (455 +/- 5 mg/d [mean +/- SEM]) or after 10."2.67The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans. ( Follmer, C; Godfrey, R; Pruitt, C; Sager, PT; Uppal, P, 1994)
"In 6 patients, arrhythmias were controlled after extracorporeal membrane oxygenation (ECMO) support; 5 of these patients survived."1.72Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises. ( Azamian, M; Beach, CM; Ceresnak, SR; Delauz, CM; Ehsan, SA; Glinton, KE; Houck, KM; Howard, TS; Janson, CM; Jardine, K; Kannankeril, PJ; Kava, M; Kim, JJ; Lalani, SR; Lay, EJ; Li, N; Liberman, L; Macicek, SL; Milewicz, DM; Miyake, CY; Pham, TD; Robertson, T; Soler-Alfonso, C; Stephens, SB; Tosur, M; Valdes, SO; Webster, G; Xu, W; Zhang, L, 2022)
"To our knowledge, presentation of ventricular tachycardia caused by primary hyperparathyroidism in such a young patient has not been reported in medical literature so far."1.48Ventricular tachycardia in a 16-year-old boy with primary hyperparathyroidism. ( Dilber, D; Marčinković, N; Velagić, V, 2018)
"We aimed to elucidate arrhythmia mechanisms in a RyR2-linked CPVT mutation (RyR2-A4860G) that depresses channel activity."1.42Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function. ( Gurrola, GB; Jalife, J; Moss, RL; Powers, PP; Valdivia, CR; Valdivia, HH; Willis, BC; Zhao, YT, 2015)
"Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia characterized by syncope and sudden death occurring during exercise or acute emotion."1.42Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations. ( Arad, M; Barad, L; Binah, O; Eisen, B; Eldar, M; Eldor, L; Gherghiceanu, M; Itskovitz-Eldor, J; Lorber, A; Novak, A; Reiter, I, 2015)
"Exercise-related ventricular tachycardia (VT) and high burden of premature ventricular contractions (PVCs) are common in arrhythmogenic right ventricular dysplasia/cardiomyopathy."1.39High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. ( Bhonsale, A; Calkins, H; James, C; Laurita, KR; Madhavan, S; Murray, B; Nazarian, S; Needleman, M; Philips, B; Tandri, H; Tichnell, C, 2013)
"Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by mutations in cardiac ryanodine receptor (RyR2) or calsequestrin (Casq2) genes."1.39Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients. ( Faggioni, M; Hwang, HS; Kannankeril, PJ; Knollmann, BC; Nederend, I; van der Werf, C; Wilde, AA, 2013)
"We also observed polymorphic ventricular tachycardia in the CASQ2(D307H) mice, although lesser than in the CASQ2 null mice."1.38Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background. ( Belevych, AE; Gyorke, S; Hwang, HS; Kalyanasundaram, A; Knollmann, BC; Lacombe, VA; Periasamy, M; Viatchenko-Karpinski, S, 2012)
"Catecholaminergic polymorphic ventricular tachycardia is characterized by stress-triggered syncope and sudden death."1.38Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia. ( Benitah, JP; Gómez, AM; Liu, N; Mangoni, ME; Mesirca, P; Napolitano, C; Neco, P; Priori, SG; Richard, S; Torrente, AG; Zorio, E, 2012)
"In some patients with clinical paroxysmal supraventricular tachycardia (PSVT), who are candidates for radiofrequency (RF) catheter ablation, attempts for the induction of arrhythmia during the electrophysiological study (EPS) fail despite different stimulation protocols even during the isoproterenol infusion and atropine injection."1.37A new method for induction of atrioventricular nodal reentrant tachycardia in non-inducible cases. ( Davoodi, GR; Fakhrzadeh, H; Ghazanchai, F; Kazemisaeid, A; Vasheghani Farahani, A; Yamini Sharif, A, 2011)
"Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by a single point mutation in a well-defined region of the cardiac type 2 ryanodine receptor (RyR)2."1.36Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor. ( Doi, M; Ikeda, Y; Ikemoto, N; Kobayashi, S; Matsuzaki, M; Oda, T; Ohkusa, T; Okuda, S; Ono, M; Suetomi, T; Tateishi, H; Uchinoumi, H; Xu, X; Yamamoto, T; Yano, M, 2010)
"We describe a 71-year-old man with a ventricular tachycardia (VT) originating from the mitral annulus."1.33Idiopathic ventricular tachycardia originating from the posteroseptal mitral annulus: a case report. ( Ashikaga, K; Tashiro, H; Tsuchiya, T; Yamamoto, K, 2006)
"Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an autosomal dominant inherited disorder characterized by adrenergic induced polymorphic ventricular tachycardias and associated with sudden cardiac death."1.33A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia. ( Aizawa, Y; Chinushi, M; Hayashi, T; Hiraoka, M; Inagaki, N; Kimura, A; Komura, S; Matsumoto, Y; Nakano, N; Takahashi, M; Ueda, K; Washizuka, T; Yasunami, M, 2005)
"Although catecholaminergic polymorphic ventricular tachycardia (CPVT) is associated with fatal ventricular arrhythmias and sudden death, the ECG findings are not fully understood."1.33Distinct U wave changes in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT). ( Aizawa, Y; Chinushi, M; Komura, S; Morita, H; Ohe, T; Okada, S, 2006)
"Ventricular arrhythmias can cause sudden cardiac death (SCD) in patients with normal hearts and in those with underlying disease such as heart failure."1.32Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. ( Cervantes, D; Coromilas, J; Deng, SX; Landry, DW; Lehnart, SE; Marks, AR; Reiken, SR; Vest, JA; Wehrens, XH, 2004)
"Ventricular tachyarrhythmias were initiated in TG mice by programmed stimulation but not in WT and were accelerated by isoproterenol."1.32Electrophysiological consequences of human IKs channel expression in adult murine heart. ( Cabo, C; Chiello Tracy, C; Coromilas, J; Kass, RS; Kurokawa, J; Wit, AL, 2003)
"Exercise test-induced ventricular tachycardia was nonsustained in 17 patients and sustained in 2 cases."1.31Adrenergic nervous system influences on the induction of ventricular tachycardia. ( Beloscar, JS; Mariani, E; Pellizzón, OA, 2002)
"13 patients whose ventricular tachycardia was treated with RF ablation were followed up more than 18 months after RF ablation."1.30Radiofrequency catheter ablation for idiopathic right ventricular tachycardia with special reference to morphological variation and long-term outcome. ( Aizawa, Y; Chinushi, M; Kitazawa, H; Shibata, A; Takahashi, K, 1997)
"Supraventricular tachyarrhythmias (SVTA) may occur in patients with the arrhythmogenic right ventricular dysplasia (ARVD)."1.30Increased atrial vulnerability in arrhythmogenic right ventricular disease. ( Berder, V; Beurrier, D; Brembilla-Perrot, B; Houplon, P; Houriez, P; Jacquemin, L; Louis, P; Terrier de la Chaise, A, 1998)
"Therefore, in patients with idiopathic ventricular tachycardia, even if the induction of tachycardia requires infusion of isoproterenol, successful pace mapping may be performed in its absence."1.30Effect of isoproterenol on QRS complex morphology during ventricular pacing: implications for pace mapping. ( Bahu, M; Daoud, EG; Goyal, R; Knight, BP; Man, KC; Morady, F; Mukhopadhyay, PS; Strickberger, SA; Syed, ZA; Weiss, R, 1998)
"Isoproterenol was administered as a loading dosage of 0."1.30Use-dependent electrophysiologic effects of DL-sotalol and modulation by isoproterenol in the human ventricle. ( Aizawa, Y; Furushima, H; Naitoh, N; Ohira, K; Taneda, K, 1998)
"During isoprenaline infusion, ventricular tachycardia originating from the right ventricular outflow tract (RVOT) with a cycle length of 280 ms was induced and subsequently atrioventricular reentrant tachycardia (AVRT) with a cycle length of 300 ms using an accessory pathway in the left free wall appeared."1.30AV reentrant and idiopathic ventricular double tachycardias: complicated interactions between two tachycardias. ( Aizawa, Y; Niwano, S; Tsuchida, K; Washizuka, T, 1999)
"5+/-4, p = 0."1.30Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study-guided effective pharmacological therapy. ( Aizawa, Y; Izumi, T; Kitano, Y; Moriguchi, M; Niwano, S; Yamaura, M; Yoshizawa, N, 1999)
"Sustained ventricular tachycardia with right bundle branch block morphology and left- or right-axis deviation was documented in all patients."1.29Idiopathic left ventricular tachycardia: new insights into electrophysiological characteristics and radiofrequency catheter ablation. ( Borggrefe, M; Breithardt, G; Chen, X; Haverkamp, W; Hindricks, G; Kottkamp, H; Wichter, T; Willems, S, 1995)
"The site of the origin of ventricular tachycardia was localized in the right ventricular outflow tract in both cases."1.29[Catheter ablation of tachycardia of the outlet right ventricle using radiofrequency as power source]. ( Balbão, CE; da Silva, RM; de Paola, AA; Hara, VM; Martinez Filho, EE; Mendonça, A; Netto, Oda S; Portugal, OP; Tavora, MZ, 1993)
"Syncope associated with paroxysmal atrial fibrillation has been interpreted as an ominous finding predictive of rapid ventricular rates."1.29Role of autonomic reflexes in syncope associated with paroxysmal atrial fibrillation. ( Bottoni, N; Brignole, M; Gianfranchi, L; Lolli, G; Menozzi, C; Oddone, D; Raviele, A, 1993)
"Isoproterenol infusion was required for tachycardia induction in 50% of patients, 44% of whom had VT with a left bundle branch block QRS pattern, with the remaining 56% exhibiting VT with a right bundle branch block pattern."1.29Spectrum of electrophysiologic and electropharmacologic characteristics of verapamil-sensitive ventricular tachycardia in patients without structural heart disease. ( Chun, H; Lai, WT; Lauer, MR; Lee, KL; Liem, LB; Sung, RJ; Tai, YT; Young, C, 1996)
"The diagnosis of ventricular tachycardia could therefore be continued."1.29[Should protocol of programmed ventricular stimulation be adapted to each patient? ]. ( Brembilla-Perrot, B; Houplon, P; Jacquemin, L; Lemoine, C; Mathieu, P, 1996)
"Polymorphic arrhythmia occurred in 80% of cases, but left lag forms predominated."1.28[Complementary value of the isoprenaline test and high-amplification ECG in the diagnosis of arrhythmogenic dysplasia of the right ventricle]. ( Barat, JL; Chavernac, P; Haissaguerre, M; Héraudeau, A; Le Métayer, P; Montserrat, P; Warin, JF, 1992)

Research

Studies (109)

TimeframeStudies, this research(%)All Research%
pre-19905 (4.59)18.7374
1990's30 (27.52)18.2507
2000's36 (33.03)29.6817
2010's35 (32.11)24.3611
2020's3 (2.75)2.80

Authors

AuthorsStudies
Aras, K1
Gams, A1
Faye, NR1
Brennan, J1
Goldrick, K1
Li, J1
Zhong, Y1
Chiang, CH1
Smith, EH1
Poston, MD1
Chivers, J1
Hanna, P1
Mori, S1
Ajijola, OA1
Shivkumar, K1
Hoover, DB1
Viventi, J1
Rogers, JA1
Bernus, O1
Efimov, IR1
Miyake, CY1
Lay, EJ1
Beach, CM1
Ceresnak, SR2
Delauz, CM1
Howard, TS1
Janson, CM1
Jardine, K1
Kannankeril, PJ3
Kava, M1
Kim, JJ1
Liberman, L1
Macicek, SL1
Pham, TD1
Robertson, T1
Valdes, SO1
Webster, G1
Stephens, SB1
Milewicz, DM1
Azamian, M1
Ehsan, SA1
Houck, KM1
Soler-Alfonso, C1
Glinton, KE1
Tosur, M1
Li, N2
Xu, W1
Lalani, SR1
Zhang, L1
Mollenhauer, M1
Mehrkens, D1
Klinke, A1
Lange, M1
Remane, L1
Friedrichs, K1
Braumann, S1
Geißen, S1
Simsekyilmaz, S1
Nettersheim, FS1
Lee, S1
Peinkofer, G1
Geisler, AC1
Geis, B1
Schwoerer, AP1
Carrier, L1
Freeman, BA1
Dewenter, M1
Luo, X1
El-Armouche, A1
Wagner, M1
Adam, M1
Baldus, S1
Rudolph, V1
Denis, A2
Sacher, F2
Derval, N2
Martin, R1
Lim, HS1
Pambrun, T1
Massoullie, G1
Duchateau, J1
Cochet, H2
Pillois, X2
Cheniti, G1
Frontera, A2
Takigawa, M1
Vlachos, K1
Martin, C1
Kitamura, T1
Hocini, M2
Douard, H1
Jaïs, P2
Haïssaguerre, M3
Marinheiro, R1
Parreira, L1
Amador, P1
Sardinha, F1
Gonçalves, S1
Serra, S1
Marčinković, N1
Dilber, D1
Velagić, V1
Wang, Y2
Patel, D1
Wang, DW2
Yan, JT1
Hsia, HH1
Liu, H1
Zhao, CX1
Zuo, HJ1
Bai, Y1
Jones, PP1
Guo, J1
Zhong, X1
Clark, RB1
Zhou, Q1
Wang, R1
Vallmitjana, A1
Benitez, R1
Hove-Madsen, L1
Semeniuk, L1
Guo, A1
Song, LS1
Duff, HJ1
Chen, SR1
Nayyar, S1
Roberts-Thomson, KC1
Hasan, MA1
Sullivan, T1
Harrington, J1
Sanders, P1
Baumert, M1
Maury, P1
Hascoët, S1
Mondoly, P1
Acar, P1
Fukuda, M1
Yamamoto, T2
Nishimura, S1
Kato, T1
Murakami, W1
Hino, A1
Ono, M2
Tateishi, H2
Oda, T2
Okuda, S2
Kobayashi, S2
Koseki, N1
Kyushiki, H1
Yano, M2
Tsui, H1
Ke, Y1
Shi, Y1
Li, Y1
Davies, L1
Cartwright, EJ1
Venetucci, L1
Zhang, H1
Terrar, DA1
Huang, CL3
Solaro, RJ1
Wang, X1
Lei, M1
Zhao, YT1
Valdivia, CR1
Gurrola, GB1
Powers, PP1
Willis, BC1
Moss, RL1
Jalife, J1
Valdivia, HH1
Tsai, WC1
Lu, YY1
Chen, YC1
Chang, CJ1
Kao, YH1
Lin, YK1
Chen, YH1
Chen, SA1
Yang, LY1
Chen, YJ1
Gopi, A1
Nair, SG1
Shelke, A1
Saggu, DK1
Yalagudri, S1
Reddy, P1
Narasimhan, C1
Novak, A2
Barad, L2
Lorber, A3
Gherghiceanu, M1
Reiter, I1
Eisen, B1
Eldor, L1
Itskovitz-Eldor, J2
Eldar, M2
Arad, M1
Binah, O2
Berte, B1
Amraoui, S1
Yamashita, S1
Komatsu, Y1
Mahida, S1
Wielandts, JY1
Sellal, JM1
Al Jefairi, N1
Montaudon, M1
Laurent, F1
Liu, B1
Ho, HT1
Brunello, L1
Unudurthi, SD1
Lou, Q1
Belevych, AE2
Qian, L1
Kim, DH1
Cho, C1
Janssen, PM1
Hund, TJ1
Knollmann, BC5
Kranias, EG1
Györke, S3
Ferrantini, C1
Coppini, R1
Scellini, B1
Ferrara, C1
Pioner, JM1
Mazzoni, L1
Priori, S1
Cerbai, E1
Tesi, C1
Poggesi, C1
Paavola, J1
Väänänen, H1
Larsson, K1
Penttinen, K1
Toivonen, L1
Kontula, K1
Laine, M1
Aalto-Setälä, K1
Swan, H1
Viitasalo, M1
Patocskai, B1
Barajas-Martinez, H1
Hu, D1
Gurabi, Z1
Koncz, I1
Antzelevitch, C2
Sasaki, K1
Makiyama, T1
Yoshida, Y1
Wuriyanghai, Y1
Kamakura, T1
Nishiuchi, S1
Hayano, M1
Harita, T1
Yamamoto, Y1
Kohjitani, H1
Hirose, S1
Chen, J1
Kawamura, M2
Ohno, S1
Itoh, H1
Takeuchi, A1
Matsuoka, S1
Miura, M1
Sumitomo, N2
Horie, M2
Yamanaka, S1
Kimura, T1
Beyer, A1
Ganti, B1
Majkrzak, A1
Theyyunni, N1
Hothi, SS1
Gurung, IS1
Heathcote, JC1
Zhang, Y1
Booth, SW1
Skepper, JN1
Grace, AA2
Allocca, G1
Proclemer, A1
Nucifora, G1
Dall'Armellina, E1
Rebellato, L1
Atiyeh, RH1
Arthur, ME1
Berman, AE1
Castresana, MR1
Roten, L1
Tanner, H1
Fernández-Velasco, M2
Rueda, A1
Rizzi, N1
Benitah, JP3
Colombi, B1
Napolitano, C4
Priori, SG4
Richard, S3
Gómez, AM3
Jastrzebski, M1
Uchinoumi, H1
Suetomi, T1
Xu, X1
Doi, M1
Ikeda, Y1
Ohkusa, T1
Ikemoto, N1
Matsuzaki, M1
Yiu, KH1
Tse, HF1
Lau, CP1
Kashimura, T1
Briston, SJ1
Trafford, AW1
Eisner, DA1
Venetucci, LA1
Ye, L1
Zhu, W1
Backx, PH1
Cortez, MA1
Wu, J1
Chow, YH1
McKerlie, C1
Wang, A1
Tsui, LC1
Gross, GJ1
Hu, J1
Pass, RH1
Liu, N2
Denegri, M1
Ruan, Y1
Avelino-Cruz, JE1
Perissi, A1
Negri, S1
Coetzee, WA1
Boyden, PA1
Yamini Sharif, A1
Vasheghani Farahani, A1
Davoodi, GR1
Kazemisaeid, A1
Fakhrzadeh, H1
Ghazanchai, F1
Ashikaga, K1
Tsuchiya, T1
Tashiro, H1
Yamamoto, K1
Page, SP1
Pfeffer, C1
Schilling, RJ1
Sporton, SC1
Kalyanasundaram, A2
Viatchenko-Karpinski, S2
Lacombe, VA2
Hwang, HS2
Periasamy, M2
Zeevi-Levin, N1
Shick, R1
Shtrichman, R1
Johnson, CM1
Pogwizd, SM1
Neco, P1
Torrente, AG1
Mesirca, P1
Zorio, E1
Mangoni, ME1
Qin, M1
Liu, T1
Hu, H1
Wang, T1
Yu, S1
Huang, C1
Philips, B1
Madhavan, S1
James, C1
Tichnell, C1
Murray, B1
Needleman, M1
Bhonsale, A1
Nazarian, S1
Laurita, KR2
Calkins, H1
Tandri, H1
Faggioni, M1
van der Werf, C1
Nederend, I1
Wilde, AA1
Chiello Tracy, C1
Cabo, C1
Coromilas, J2
Kurokawa, J1
Kass, RS1
Wit, AL1
Pellizzón, OA1
Beloscar, JS1
Mariani, E1
Odashiro, K1
Hiramatsu, S1
Yanagi, N1
Arita, T1
Maruyama, T1
Kaji, Y1
Harada, M1
Kirchhof, P1
Sirenko, SG1
Degen, H1
Greene, AE1
Schober, T1
Mackow, JC1
Fabritz, L1
Potter, JD1
Morad, M1
George, CH1
Higgs, GV1
Lai, FA1
Obreztchikova, MN1
Sosunov, EA2
Anyukhovsky, EP1
Moïse, NS2
Robinson, RB1
Rosen, MR2
LINENTHAL, AJ1
ZOLL, PM1
UNDERHILL, WL1
TREDWAY, JB1
PINAR, S1
SCHUERHOLZ, K1
FOLDENAUER, A1
STUMPF, P1
BOEHM, P1
MATTHEWS, RJ1
Wehrens, XH1
Lehnart, SE1
Reiken, SR1
Deng, SX1
Vest, JA1
Cervantes, D1
Landry, DW1
Marks, AR1
Balasubramaniam, R1
Chawla, S1
Mackenzie, L1
Schwiening, CJ1
Katra, RP1
Aizawa, Y10
Ueda, K1
Komura, S2
Washizuka, T2
Chinushi, M4
Inagaki, N1
Matsumoto, Y1
Hayashi, T2
Takahashi, M1
Nakano, N1
Yasunami, M1
Kimura, A1
Hiraoka, M3
Nam, GB1
Burashnikov, A1
Komiya, N1
Seto, S1
Nakao, K1
Yano, K1
Topilski, I1
Glick, A1
Viskin, S1
Belhassen, B1
Hayashi, M1
Okazaki, H1
Igei, S1
Inada, K1
Matuo, S1
Date, T1
Yagi, H1
Yamane, T1
Sugimoto, K1
Mochizuki, S1
Okada, S1
Morita, H1
Ohe, T1
Dirksen, WP1
Chi, M1
Terentyev, D1
Zhou, Z1
Vedamoorthyrao, S1
Chiamvimonvat, N1
Carnes, CA1
Franzini-Armstrong, C2
Faber, GM1
Rudy, Y1
Joshi, S1
Raiszadeh, F1
Pierce, W1
Steinberg, JS1
Chopra, N1
Yang, T1
Hlaing, T1
Holinstat, I1
Ettensohn, K1
Pfeifer, K1
Akin, B1
Jones, LR1
Yamawake, N1
Nishizaki, M1
Niki, S1
Maeda, S1
Tanaka, Y1
Fujii, H1
Ashikaga, T1
Sakurada, H2
Shannon, TR1
Taniguchi, K1
Matsumura, M1
Abe, O1
Miyashita, M1
Kanamaru, H1
Karasawa, K1
Ayusawa, M1
Fukamizu, S1
Nagaoka, I1
Harada, K1
Galindo-Tovar, A1
Kaumann, AJ1
Gellen, B1
Briec, F1
Vinet, L1
LeQuang, K1
Rouet-Benzineb, P1
Pezet, M1
Palais, G1
Pellegrin, N1
Zhang, A1
Perrier, R1
Escoubet, B1
Marniquet, X1
Jaisser, F1
Charpentier, F1
Mercadier, JJ1
Wienecke, M1
Case, C1
Buckles, D1
Gillette, P1
Kobayashi, Y2
Kikushima, S1
Tanno, K1
Kurano, K1
Baba, T1
Katagiri, T2
Mittleman, RS1
Candinas, R1
Collett-Willey, P1
Huang, SK1
Li, HG1
Yee, R1
Klein, GJ1
Kottkamp, H1
Chen, X1
Hindricks, G1
Willems, S1
Haverkamp, W1
Wichter, T1
Breithardt, G1
Borggrefe, M1
Sager, PT2
Follmer, C1
Uppal, P1
Pruitt, C1
Godfrey, R1
Ng, KS1
Wen, MS1
Yeh, SJ1
Lin, FC1
Wu, D1
de Paola, AA1
Netto, Oda S1
Balbão, CE1
Mendonça, A1
Tavora, MZ1
da Silva, RM1
Hara, VM1
Portugal, OP1
Martinez Filho, EE1
Brignole, M1
Gianfranchi, L1
Menozzi, C1
Raviele, A1
Oddone, D1
Lolli, G1
Bottoni, N1
Markel, ML1
Miles, WM1
Luck, JC1
Klein, LS1
Prystowsky, EN1
Brodsky, MA1
Orlov, MV1
Allen, BJ1
Orlov, YS1
Wolff, L1
Winters, R1
Niebauer, M1
Daoud, E1
Goyal, R3
Chan, KK1
Harvey, M1
Bogun, F1
Castellani, M1
Man, KC3
Strickberger, SA3
Morady, F3
Lee, KL1
Lauer, MR1
Young, C1
Lai, WT1
Tai, YT1
Chun, H1
Liem, LB1
Sung, RJ1
Behboodikhah, M1
Brembilla-Perrot, B2
Houplon, P2
Jacquemin, L2
Lemoine, C1
Mathieu, P1
de Meester, A1
Chaudron, JM1
de Roy, L1
Takahashi, K1
Kitazawa, H2
Shibata, A2
Houriez, P1
Beurrier, D1
Berder, V1
Terrier de la Chaise, A1
Louis, P1
Mukhopadhyay, PS1
Syed, ZA1
Knight, BP1
Bahu, M1
Weiss, R1
Daoud, EG1
Song, Y1
Shryock, JC1
Belardinelli, L1
Naitoh, N2
Furushima, H1
Ohira, K1
Taneda, K1
Yamaura, M2
Tagawa, M1
Niwano, S2
Tsuchida, K1
Yoshizawa, N1
Moriguchi, M1
Kitano, Y1
Izumi, T1
Fisher, JD1
Krikler, D1
Hallidie-Smith, KA1
Kou, WH1
Gainullin, RZ1
Steinberg, SF1
Danilo, P1
Suzuki, H1
Torigoe, K1
Numata, O1
Yazaki, S1
Yazawa, T1
Adachi, T1
Ryu, S1
Asano, T1
Obara, C1
Han, W1
Wang, Z1
Nattel, S1
Lahat, H1
Levy-Nissenbaum, E1
Bahan, T1
Friedman, E1
Khoury, A1
Kastner, DL1
Goldman, B1
Pras, E1
DeLacey, WA1
Nath, S1
Haines, DE1
Barber, MJ1
DiMarco, JP1
Chavernac, P1
Le Métayer, P1
Barat, JL1
Montserrat, P1
Héraudeau, A1
Warin, JF1
Kuwano, H1
Hosono, H1
Kusano, Y1
Naitho, N1
Tamura, M1
Wiesfeld, AC1
Crijns, HJ1
Van Veldhuisen, DJ1
Van Gilst, WH1
Lie, KI1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Multi-center, Controlled Trial to Compare the Feasibility, Safety and Efficacy of Zero-fluoroscopic Approach With Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia[NCT03042078]3,060 participants (Actual)Interventional2012-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for isoproterenol and Tachycardia, Ventricular

ArticleYear
Effect of isoproterenol on accessory pathways without overt retrograde conduction.
    Journal of cardiovascular electrophysiology, 1995, Volume: 6, Issue:3

    Topics: Accessory Nerve; Adolescent; Adult; Aged; Atrioventricular Node; Bundle of His; Electrocardiography;

1995
The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
    Circulation, 1994, Volume: 90, Issue:4

    Topics: Action Potentials; Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Ele

1994

Other Studies

107 other studies available for isoproterenol and Tachycardia, Ventricular

ArticleYear
Electrophysiology and Arrhythmogenesis in the Human Right Ventricular Outflow Tract.
    Circulation. Arrhythmia and electrophysiology, 2022, Volume: 15, Issue:3

    Topics: Acetylcholine; Adrenergic Agents; Cardiac Electrophysiology; Cholinergic Agents; Electrocardiography

2022
Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises.
    Heart rhythm, 2022, Volume: 19, Issue:10

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Child; Heart Arrest; Humans; Isoprot

2022
Nitro-fatty acids suppress ischemic ventricular arrhythmias by preserving calcium homeostasis.
    Scientific reports, 2020, 09-18, Volume: 10, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Calcium-Calmodulin-Dependent Protein

2020
Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2018, 06-01, Volume: 20, Issue:FI1

    Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Arrhythmogenic Right Ventricular Dysplasia; Case

2018
Primary Ventricular Fibrillation in a Patient with Mild Hypercalcemia.
    Arquivos brasileiros de cardiologia, 2018, Volume: 110, Issue:4

    Topics: Adult; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Hypercalcemia; Hyperparathyroidi

2018
Ventricular tachycardia in a 16-year-old boy with primary hyperparathyroidism.
    Cardiology in the young, 2018, Volume: 28, Issue:11

    Topics: Adolescent; Adrenergic beta-Agonists; Calcium; Electrocardiography; Humans; Hypercalcemia; Hyperpara

2018
β1-Adrenoceptor blocker aggravated ventricular arrhythmia.
    Pacing and clinical electrophysiology : PACE, 2013, Volume: 36, Issue:11

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Adult; Aminophylline; Female; Huma

2013
Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice.
    Circulation research, 2013, Aug-16, Volume: 113, Issue:5

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e

2013
Autonomic modulation of repolarization instability in patients with heart failure prone to ventricular tachycardia.
    American journal of physiology. Heart and circulatory physiology, 2013, Oct-15, Volume: 305, Issue:8

    Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Adult; Aged; Autonomic

2013
Monomorphic sustained ventricular tachycardia late after arterial switch for d-transposition of the great arteries: ablation in the sinus of valsalva.
    The Canadian journal of cardiology, 2013, Volume: 29, Issue:12

    Topics: Adolescent; Atropine; Cardiac Pacing, Artificial; Catheter Ablation; Coronary Vessel Anomalies; Elec

2013
Enhanced binding of calmodulin to RyR2 corrects arrhythmogenic channel disorder in CPVT-associated myocytes.
    Biochemical and biophysical research communications, 2014, May-23, Volume: 448, Issue:1

    Topics: Action Potentials; Animals; Calmodulin; Gene Knock-In Techniques; Isoproterenol; Mice; Myocytes, Car

2014
Pak1 is required to maintain ventricular Ca²⁺ homeostasis and electrophysiological stability through SERCA2a regulation in mice.
    Circulation. Arrhythmia and electrophysiology, 2014, Volume: 7, Issue:5

    Topics: Adrenergic beta-Agonists; Animals; Calcium; Cardiac Pacing, Artificial; Cardiomegaly; Cells, Culture

2014
Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.
    Proceedings of the National Academy of Sciences of the United States of America, 2015, Mar-31, Volume: 112, Issue:13

    Topics: Animals; Arrhythmias, Cardiac; Calcium; Heart; Heterozygote; Homozygote; Humans; Isoproterenol; Mice

2015
Ablation of androgen receptor gene triggers right ventricular outflow tract ventricular tachycardia.
    International journal of cardiology, 2015, Jun-15, Volume: 189

    Topics: Action Potentials; Adenosine; Animals; Caffeine; Calcium; Flecainide; Gene Knockdown Techniques; Gen

2015
A stepwise approach to the induction of idiopathic fascicular ventricular tachycardia.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2015, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Aged; Atropine; Cardiotonic Agents; Catheter Ablation; Electric Stimulation; Elec

2015
Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.
    Journal of cellular and molecular medicine, 2015, Volume: 19, Issue:8

    Topics: Base Sequence; Caffeine; Calcium Signaling; Calsequestrin; Cell Differentiation; Genotyping Techniqu

2015
Characterization of the Left-Sided Substrate in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Circulation. Arrhythmia and electrophysiology, 2015, Volume: 8, Issue:6

    Topics: Adrenergic beta-Agonists; Adult; Arrhythmogenic Right Ventricular Dysplasia; Electrocardiography; El

2015
Ablation of HRC alleviates cardiac arrhythmia and improves abnormal Ca handling in CASQ2 knockout mice prone to CPVT.
    Cardiovascular research, 2015, 11-01, Volume: 108, Issue:2

    Topics: Animals; Calcium; Calcium-Binding Proteins; Calsequestrin; Disease Models, Animal; Echocardiography;

2015
R4496C RyR2 mutation impairs atrial and ventricular contractility.
    The Journal of general physiology, 2016, Volume: 147, Issue:1

    Topics: Animals; Arrhythmias, Cardiac; Calcium; Calcium Channels, L-Type; Calcium Signaling; Heart Atria; He

2016
Slowed depolarization and irregular repolarization in catecholaminergic polymorphic ventricular tachycardia: a study from cellular Ca2+ transients and action potentials to clinical monophasic action potentials and electrocardiography.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2016, Volume: 18, Issue:10

    Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Calcium Signaling; Case-Control Studies; Electro

2016
Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
    Heart rhythm, 2016, Volume: 13, Issue:6

    Topics: Action Potentials; Animals; Cardiac Electrophysiology; Cardiovascular Agents; Cilostazol; Death, Sud

2016
Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Action Potentials; Adult; Animals; Anti-Asthmatic Agents; Calcium; Calreticulin; Calsequestrin; Cell

2016
A Perfect Storm: Tyrosine Kinase Inhibitor-Associated Polymorphic Ventricular Tachycardia.
    The Journal of emergency medicine, 2017, Volume: 52, Issue:4

    Topics: Adenine; Amiodarone; Anti-Arrhythmia Agents; Antineoplastic Agents; Cardiotonic Agents; Electric Cou

2017
Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart.
    Pflugers Archiv : European journal of physiology, 2008, Volume: 457, Issue:2

    Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Benzylamines; Calcium Signaling; Calcium-Calmo

2008
Monomorphic ventricular tachycardia in 'Brugada syndrome': clinical case and literature review.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2008, Volume: 9, Issue:8

    Topics: Adrenergic beta-Agonists; Adult; Brugada Syndrome; Electrocardiography; Follow-Up Studies; Heart Rat

2008
The utility of ketamine in facilitating the induction of isoproterenol-refractory idiopathic ventricular tachyarrhythmias.
    Journal of cardiothoracic and vascular anesthesia, 2009, Volume: 23, Issue:3

    Topics: Drug Synergism; Electrocardiography; Female; Humans; Isoproterenol; Ketamine; Tachycardia, Ventricul

2009
Irregular tachycardia: what is the mechanism? Part I.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2009, Volume: 11, Issue:1

    Topics: Cardiotonic Agents; Diagnosis, Differential; Electrocardiography; Humans; Isoproterenol; Tachycardia

2009
Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.
    Circulation research, 2009, Jan-30, Volume: 104, Issue:2

    Topics: Adrenergic beta-Agonists; Animals; Caffeine; Calcium Signaling; Cardiac Pacing, Artificial; Catechol

2009
Double fire or junctional ectopy?
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2009, Volume: 11, Issue:8

    Topics: Cardiotonic Agents; Diagnosis, Differential; Electrocardiography; Humans; Isoproterenol; Tachycardia

2009
Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.
    Circulation research, 2010, Apr-30, Volume: 106, Issue:8

    Topics: Animals; Caffeine; Calcium Signaling; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Disease

2010
Ventricular tachycardia complicating head-up tilt test: the role of coronary artery spasm.
    Pacing and clinical electrophysiology : PACE, 2011, Volume: 34, Issue:12

    Topics: Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Cardiopulmonary Resuscitation; Cardiotoni

2011
In the RyR2(R4496C) mouse model of CPVT, β-adrenergic stimulation induces Ca waves by increasing SR Ca content and not by decreasing the threshold for Ca waves.
    Circulation research, 2010, Dec-10, Volume: 107, Issue:12

    Topics: Adrenergic Agents; Animals; Calcium; Calcium Signaling; Disease Models, Animal; Isoproterenol; Mice;

2010
Arrhythmia and sudden death associated with elevated cardiac chloride channel activity.
    Journal of cellular and molecular medicine, 2011, Volume: 15, Issue:11

    Topics: Animals; Arrhythmias, Cardiac; Atrioventricular Block; Atrioventricular Node; Bradycardia; Cardiac P

2011
Wolff-Parkinson-White syndrome and isoproterenol testing in children: a valid adjunct to predict risk?
    Circulation. Arrhythmia and electrophysiology, 2011, Volume: 4, Issue:1

    Topics: Adolescent; Cardiac Catheterization; Cardiotonic Agents; Catheter Ablation; Child; Child, Preschool;

2011
Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity.
    Circulation research, 2011, Jul-22, Volume: 109, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Calcium Signaling; Disease Models, Animal; Extracellular Space; Fle

2011
A new method for induction of atrioventricular nodal reentrant tachycardia in non-inducible cases.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2011, Volume: 13, Issue:12

    Topics: Adult; Atropine; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Female; Follow-Up Studie

2011
Idiopathic ventricular tachycardia originating from the posteroseptal mitral annulus: a case report.
    Journal of cardiovascular electrophysiology, 2006, Volume: 17, Issue:12

    Topics: Adenosine Triphosphate; Aged; Cardiotonic Agents; Catheter Ablation; Cyclic AMP; Exercise; Humans; I

2006
Dual ventricular response: what is the mechanism?
    Journal of cardiovascular electrophysiology, 2012, Volume: 23, Issue:6

    Topics: Action Potentials; Adrenergic beta-Agonists; Cardiac Pacing, Artificial; Catheter Ablation; Electroc

2012
Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background.
    American journal of physiology. Heart and circulatory physiology, 2012, Jan-01, Volume: 302, Issue:1

    Topics: Animals; Calcium; Calcium Signaling; Calsequestrin; Cardiac Pacing, Artificial; Cardiotonic Agents;

2012
Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation.
    Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:3

    Topics: Adrenergic beta-Agonists; Adult; Calcium; Calcium Signaling; Calsequestrin; Cell Differentiation; Ch

2012
Focal initiation of sustained and nonsustained ventricular tachycardia in a canine model of ischemic cardiomyopathy.
    Journal of cardiovascular electrophysiology, 2012, Volume: 23, Issue:5

    Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Cardiac Pacing, Artificial; Cardiomyopathies;

2012
Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
    Circulation, 2012, Jul-24, Volume: 126, Issue:4

    Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Aged; Animals; Calcium; Calcium Signaling; Disea

2012
Effect of isoprenaline chronic stimulation on APD restitution and ventricular arrhythmogenesis.
    Journal of cardiology, 2013, Volume: 61, Issue:2

    Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Cardiac Pacing, Artificial; Cardiomegaly; Card

2013
High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Circulation. Arrhythmia and electrophysiology, 2013, Volume: 6, Issue:1

    Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Arrhythmogenic Right Ventricular Dysplasia; Balti

2013
Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients.
    Circulation research, 2013, Feb-15, Volume: 112, Issue:4

    Topics: Adult; Animals; Atropine; Bradycardia; Caffeine; Calcium Signaling; Calsequestrin; Cardiac Pacing, A

2013
Electrophysiological consequences of human IKs channel expression in adult murine heart.
    American journal of physiology. Heart and circulatory physiology, 2003, Volume: 284, Issue:1

    Topics: Adrenergic beta-Agonists; Aging; Animals; Blood Pressure; Cardiac Pacing, Artificial; Delayed Rectif

2003
Adrenergic nervous system influences on the induction of ventricular tachycardia.
    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2002, Volume: 7, Issue:4

    Topics: Adrenergic beta-Agonists; Adult; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Iso

2002
Arrhythmogenic and inotropic effects of interferon investigated in perfused and in vivo rat hearts: influences of cardiac hypertrophy and isoproterenol.
    Circulation journal : official journal of the Japanese Circulation Society, 2002, Volume: 66, Issue:12

    Topics: Animals; Arrhythmias, Cardiac; Cardiomegaly; Drug Synergism; Heart Block; Humans; In Vitro Technique

2002
Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.
    Circulation research, 2003, Mar-07, Volume: 92, Issue:4

    Topics: Action Potentials; Anesthesia; Animals; Blood Pressure; Calcium; Cardiomyopathy, Hypertrophic, Famil

2003
Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.
    Circulation research, 2003, Sep-19, Volume: 93, Issue:6

    Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Caffeine; Calcium; Cell Line; Cresols; Humans; Isoprote

2003
Heterogeneous ventricular repolarization provides a substrate for arrhythmias in a German shepherd model of spontaneous arrhythmic death.
    Circulation, 2003, Sep-16, Volume: 108, Issue:11

    Topics: Action Potentials; Animals; Cells, Cultured; Death, Sudden, Cardiac; Dogs; Electric Conductivity; He

2003
Prevention of ventricular tachycardia and fibrillation by intravenous isoproterenol and epinephrine.
    Circulation, 1963, Volume: 27

    Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Epinephrine; Heart Block;

1963
THE TREATMENT OF PAROXYSMAL VENTRICULAR TACHYCARDIA WITH ISOPROTERENOL.
    Annals of internal medicine, 1964, Volume: 60

    Topics: Electrocardiography; Infusions, Parenteral; Isoproterenol; Procainamide; Quinidine; Tachycardia; Tac

1964
[PAROXYSMAL VENTRICULAR TACHYCARDIA WITH HEART BLOCK].
    Turk Tip Cemiyeti mecmuasi, 1964, Volume: 30

    Topics: Heart Block; Isoproterenol; Procainamide; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventric

1964
[TREATMENT OF VENTRICULAR TACHYCARDIA WITH ALUPENT].
    Deutsche medizinische Wochenschrift (1946), 1965, Feb-19, Volume: 90

    Topics: Drug Therapy; Electrocardiography; Isoproterenol; Metaproterenol; Myocardial Infarction; Procainamid

1965
PREVENTION OF VENTRICULAR TACHYCARDIA AND STOKES-ADAMS SEIZURES IN COMPLETE HEART BLOCK; TREATMENT WITH LARGE DOSES OF INTRAVENOUS ISOPROTERENOL.
    Archives of internal medicine, 1965, Volume: 116

    Topics: Adams-Stokes Syndrome; Atrial Fibrillation; Drug Therapy; Electrocardiography; Geriatrics; Heart Blo

1965
Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2.
    Science (New York, N.Y.), 2004, Apr-09, Volume: 304, Issue:5668

    Topics: Animals; Anti-Arrhythmia Agents; Calcium; Calcium-Transporting ATPases; Cell Line; Cyclic AMP-Depend

2004
Nifedipine and diltiazem suppress ventricular arrhythmogenesis and calcium release in mouse hearts.
    Pflugers Archiv : European journal of physiology, 2004, Volume: 449, Issue:2

    Topics: Adrenergic beta-Agonists; Animals; Anti-Arrhythmia Agents; Calcium; Calcium Channel Blockers; Cytoso

2004
Cellular mechanism of calcium-mediated triggered activity in the heart.
    Circulation research, 2005, Mar-18, Volume: 96, Issue:5

    Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Calcium; Calcium Channels; Calcium Signaling;

2005
A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia.
    International journal of cardiology, 2005, Mar-18, Volume: 99, Issue:2

    Topics: Adrenergic beta-Agonists; Adult; Exercise Test; Humans; Isoproterenol; Male; Mutation, Missense; Pol

2005
Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia.
    Circulation, 2005, May-31, Volume: 111, Issue:21

    Topics: Action Potentials; Animals; Caffeine; Calcium; Catecholamines; Disease Models, Animal; Dogs; Dose-Re

2005
The influence of beta-adrenergic agonists and antagonists on T-wave alternans in patients with and without ventricular tachyarrhythmia.
    Pacing and clinical electrophysiology : PACE, 2005, Volume: 28, Issue:7

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Electrocardiography; Female; Humans; Isoprote

2005
Frequency of spontaneous and inducible atrioventricular nodal reentry tachycardia in patients with idiopathic outflow tract ventricular arrhythmias.
    Pacing and clinical electrophysiology : PACE, 2006, Volume: 29, Issue:1

    Topics: Adolescent; Cardiac Pacing, Artificial; Catheter Ablation; Chi-Square Distribution; Electrocardiogra

2006
[Catecholaminergic polymorphic ventricular tachycardia successfully treated by beta blocker].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2006, Jan-10, Volume: 95, Issue:1

    Topics: Adolescent; Adrenergic beta-Antagonists; Catecholamines; Female; Humans; Isoproterenol; Propranolol;

2006
Distinct U wave changes in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT).
    International heart journal, 2006, Volume: 47, Issue:3

    Topics: Adolescent; Adult; Catecholamines; Electrocardiography; Electrophysiologic Techniques, Cardiac; Exer

2006
A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.
    Cardiovascular research, 2007, Jul-01, Volume: 75, Issue:1

    Topics: Animals; Caffeine; Calcium; Calcium Signaling; Calsequestrin; Cardiotonic Agents; Death, Sudden, Car

2007
Calsequestrin mutation and catecholaminergic polymorphic ventricular tachycardia: a simulation study of cellular mechanism.
    Cardiovascular research, 2007, Jul-01, Volume: 75, Issue:1

    Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Calcium; Calcium Channels, L-Type; Calsequestr

2007
Antiarrhythmic induced electrical storm in Brugada syndrome: a case report.
    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2007, Volume: 12, Issue:3

    Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Impl

2007
Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice.
    Circulation research, 2007, Sep-14, Volume: 101, Issue:6

    Topics: Animals; Calbindin 2; Calcium; Calcium Channels; Calcium Signaling; Calsequestrin; Cardiac Pacing, A

2007
Autonomic and pharmacological responses of idiopathic ventricular tachycardia arising from the left ventricular outflow tract.
    Journal of cardiovascular electrophysiology, 2007, Volume: 18, Issue:11

    Topics: Adenosine Triphosphate; Anti-Arrhythmia Agents; Cardiotonic Agents; Catheter Ablation; Electrophysio

2007
Linking calsequestrin to lumenal control of SR Ca2+ release.
    Circulation research, 2007, Sep-14, Volume: 101, Issue:6

    Topics: Animals; Calbindin 2; Calcium; Calcium Channels; Calcium Signaling; Calsequestrin; Cardiac Pacing, A

2007
Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia.
    Circulation journal : official journal of the Japanese Circulation Society, 2007, Volume: 71, Issue:10

    Topics: Adolescent; Adult; Arrhythmia, Sinus; Cardiac Electrophysiology; Cardiotonic Agents; Child; Electroc

2007
Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
    British journal of pharmacology, 2008, Volume: 153, Issue:4

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals;

2008
Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling.
    Circulation, 2008, Apr-08, Volume: 117, Issue:14

    Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Calcium Signaling; Cardiac Pacing, Artificial;

2008
Inducible ventricular tachyarrhythmia in children with Wolff-Parkinson-White syndrome.
    The American journal of cardiology, 1994, Feb-15, Volume: 73, Issue:5

    Topics: Adolescent; Adult; Age Factors; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Child; Chi

1994
Sustained left ventricular tachycardia terminated by dipyridamole: cyclic AMP-mediated triggered activity as a possible mechanism.
    Pacing and clinical electrophysiology : PACE, 1994, Volume: 17, Issue:3 Pt 1

    Topics: Acetylcholine; Adolescent; Cardiac Complexes, Premature; Cyclic AMP; Dipyridamole; Electrocardiograp

1994
Comparison of spectral temporal mapping to the time domain signal-averaged electrocardiogram in normal subjects and in patients with coronary artery disease and sustained ventricular tachycardia.
    Pacing and clinical electrophysiology : PACE, 1994, Volume: 17, Issue:5 Pt 1

    Topics: Action Potentials; Adult; Bundle-Branch Block; Cardiac Pacing, Artificial; Coronary Disease; Electro

1994
Idiopathic left ventricular tachycardia: new insights into electrophysiological characteristics and radiofrequency catheter ablation.
    Pacing and clinical electrophysiology : PACE, 1995, Volume: 18, Issue:6

    Topics: Adult; Bundle-Branch Block; Cardiac Pacing, Artificial; Catheter Ablation; Electrocardiography; Elec

1995
The effects of adenosine on idiopathic ventricular tachycardia.
    The American journal of cardiology, 1994, Jul-15, Volume: 74, Issue:2

    Topics: Adenosine Triphosphate; Adolescent; Adult; Bundle-Branch Block; Child; Electrocardiography; Exercise

1994
[Catheter ablation of tachycardia of the outlet right ventricle using radiofrequency as power source].
    Arquivos brasileiros de cardiologia, 1993, Volume: 61, Issue:2

    Topics: Adult; Catheter Ablation; Electrocardiography; Female; Follow-Up Studies; Humans; Isoproterenol; Mid

1993
Role of autonomic reflexes in syncope associated with paroxysmal atrial fibrillation.
    Journal of the American College of Cardiology, 1993, Volume: 22, Issue:4

    Topics: Aged; Atrial Fibrillation; Autonomic Nervous System; Blood Pressure; Cardiac Pacing, Artificial; Car

1993
Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Circulation, 1993, Volume: 87, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cardiac Pacing, Artificial; Drug Therapy, Comb

1993
Clinical assessment of adrenergic tone and responsiveness to beta-blocker therapy in patients with symptomatic ventricular tachycardia and no apparent structural heart disease.
    American heart journal, 1996, Volume: 131, Issue:1

    Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adrenergic Fibers; Adult; Aged; C

1996
Use of isoproterenol during programmed ventricular stimulation in patients with coronary artery disease and nonsustained ventricular tachycardia.
    American heart journal, 1996, Volume: 131, Issue:3

    Topics: Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiotonic Agents; Coronary Disease; Fema

1996
Spectrum of electrophysiologic and electropharmacologic characteristics of verapamil-sensitive ventricular tachycardia in patients without structural heart disease.
    The American journal of cardiology, 1996, May-01, Volume: 77, Issue:11

    Topics: Adenosine; Adult; Bundle-Branch Block; Catecholamines; Electrocardiography; Female; Heart Conduction

1996
Frequency-dependent electrophysiologic effects of d,l-sotalol and quinidine and modulation by beta-adrenergic stimulation.
    Journal of cardiovascular electrophysiology, 1996, Volume: 7, Issue:2

    Topics: Action Potentials; Administration, Oral; Adrenergic beta-Agonists; Analysis of Variance; Anti-Arrhyt

1996
[Should protocol of programmed ventricular stimulation be adapted to each patient? ].
    Archives des maladies du coeur et des vaisseaux, 1996, Volume: 89, Issue:11

    Topics: Cardiac Pacing, Artificial; Cardiotonic Agents; Coronary Disease; Electrocardiography; Follow-Up Stu

1996
Usefulness of isoproterenol in the induction of clinical sustained ventricular tachycardia during electrophysiological study.
    Acta cardiologica, 1997, Volume: 52, Issue:1

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Atenolol; Cardiac Pacing, Artificial; E

1997
Radiofrequency catheter ablation for idiopathic right ventricular tachycardia with special reference to morphological variation and long-term outcome.
    Heart (British Cardiac Society), 1997, Volume: 78, Issue:3

    Topics: Adult; Aged; Cardiac Pacing, Artificial; Cardiotonic Agents; Catheter Ablation; Electric Stimulation

1997
Increased atrial vulnerability in arrhythmogenic right ventricular disease.
    American heart journal, 1998, Volume: 135, Issue:5 Pt 1

    Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Cardiotonic Agents; Diagnosis, Differential; Di

1998
Effect of isoproterenol on QRS complex morphology during ventricular pacing: implications for pace mapping.
    Journal of electrocardiology, 1998, Volume: 31, Issue:2

    Topics: Aged; Cardiac Pacing, Artificial; Cardiotonic Agents; Catheter Ablation; Electrocardiography; Female

1998
Potentiating effect of acetylcholine on stimulation by isoproterenol of L-type Ca2+ current and arrhythmogenic triggered activity in guinea pig ventricular myocytes.
    Journal of cardiovascular electrophysiology, 1998, Volume: 9, Issue:7

    Topics: Acetylcholine; Adrenergic beta-Agonists; Animals; Calcium Channels; Calcium Channels, L-Type; Drug S

1998
Use-dependent electrophysiologic effects of DL-sotalol and modulation by isoproterenol in the human ventricle.
    Japanese heart journal, 1998, Volume: 39, Issue:2

    Topics: Action Potentials; Adult; Aged; Anti-Arrhythmia Agents; Cardiotonic Agents; Drug Interactions; Elect

1998
A comparison of electrophysiologic properties between responders and non-responders to DL-sotalol among patients with ventricular tachyarrhythmia. Importance of the lack of a reverse use-dependent effect on ventricular refractoriness to responders.
    Japanese heart journal, 1998, Volume: 39, Issue:5

    Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Aged; Anti-Arrhythmia Agents; Electrocardiograph

1998
AV reentrant and idiopathic ventricular double tachycardias: complicated interactions between two tachycardias.
    Heart (British Cardiac Society), 1999, Volume: 81, Issue:3

    Topics: Adrenergic beta-Antagonists; Catheter Ablation; Humans; Isoproterenol; Male; Middle Aged; Tachycardi

1999
Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study-guided effective pharmacological therapy.
    Japanese circulation journal, 1999, Volume: 63, Issue:9

    Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Electrocardiography; Female; Follow-Up Studies; Hum

1999
Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing.
    Journal of the American College of Cardiology, 1999, Volume: 34, Issue:7

    Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; An

1999
Interaction between autonomic tone and the negative chronotropic effect of adenosine in humans.
    Pacing and clinical electrophysiology : PACE, 1999, Volume: 22, Issue:12

    Topics: Adenosine; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atropine;

1999
beta(1) and beta(2)-adrenergic receptor subtype effects in German shepherd dogs with inherited lethal ventricular arrhythmias.
    Cardiovascular research, 2000, Volume: 48, Issue:2

    Topics: Action Potentials; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Anim

2000
Infant case with a malignant form of Brugada syndrome.
    Journal of cardiovascular electrophysiology, 2000, Volume: 11, Issue:11

    Topics: Adrenergic beta-Agonists; Anti-Arrhythmia Agents; Atropine; Drug Therapy, Combination; Electrocardio

2000
Ventricular arrhythmias with left bundle branch block pattern and inferior axis: assessment of their mechanisms on the basis of response to ATP, nicorandil and verapamil.
    Japanese circulation journal, 2000, Volume: 64, Issue:11

    Topics: Adenosine Triphosphate; Adult; Anti-Arrhythmia Agents; Biological Transport, Active; Bundle-Branch B

2000
Slow delayed rectifier current and repolarization in canine cardiac Purkinje cells.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 280, Issue:3

    Topics: Acetamides; Action Potentials; Adrenergic beta-Agonists; Animals; Anti-Arrhythmia Agents; Benzodiaze

2001
Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21.
    Circulation, 2001, Jun-12, Volume: 103, Issue:23

    Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Arabs; Bradycardia; Catecholamine

2001
Adenosine and verapamil-sensitive ventricular tachycardia originating from the left ventricle: radiofrequency catheter ablation.
    Pacing and clinical electrophysiology : PACE, 1992, Volume: 15, Issue:12

    Topics: Adenosine; Bundle-Branch Block; Cardiac Pacing, Artificial; Catheter Ablation; Electrocardiography;

1992
[Complementary value of the isoprenaline test and high-amplification ECG in the diagnosis of arrhythmogenic dysplasia of the right ventricle].
    Annales de cardiologie et d'angeiologie, 1992, Volume: 41, Issue:8

    Topics: Arrhythmias, Cardiac; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Ventricles; Huma

1992
Successful radiofrequency current catheter ablation of sustained ventricular tachycardia.
    Pacing and clinical electrophysiology : PACE, 1992, Volume: 15, Issue:10 Pt 1

    Topics: Aged; Cardiac Pacing, Artificial; Catheter Ablation; Electrocardiography; Heart Conduction System; H

1992
Triggered activity as arrhythmogenic mechanism after myocardial infarction: clinical and electrophysiologic study of one case.
    Clinical cardiology, 1992, Volume: 15, Issue:9

    Topics: Aged; Cardiac Pacing, Artificial; Electric Stimulation; Electrocardiography; Exercise Test; Female;

1992